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Abstract: Certain conditions such as common mental disorders (CMDs), functional limitation (FL) 
and poor diet quality may affect the lives of individuals who suffer from chronic obstructive pul-
monary disease (COPD). This study sought to examine time trends in the prevalence of CMDs, FL 
and diet quality among male and female COPD patients living in Spain from 2006 to 2017 and to 
identify which factors were related to CMDs, FL and a poor/improvable diet quality in these pa-
tients. We performed a cross-sectional study among COPD patients aged ≥ 40 years old using data 
from the Spanish National Health Surveys conducted in 2006, 2011 and 2017, identifying a total of 
2572 COPD patients. Binary logistic regressions were performed to determine the characteristics 
related to CMDs, FL and poor/improvable diet quality. Over the years of the study, the prevalence 
of FL among female COPD patients increased (p for trend <0.001). In addition, CMDs were associ-
ated to body mass index (BMI), educational level, physical activity, smoking status, occupation, 
chronic conditions and alcohol consumption; FL was related to age, living with a partner, educa-
tional level, physical activity and chronic conditions; and poor/improvable diet quality was associ-
ated to age, smoking status, BMI and physical activity. 
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1. Introduction 
Chronic obstructive pulmonary disease (COPD) is a highly significant public health 
problem affecting around 174 million of adults aged 40 years and over, with high mor-
bidity and mortality [1]. According to World Health Organization, COPD is the third lead-
ing cause of death [2]. Moreover, this chronic condition results in a high economic burden: 
globally, previous studies report that the direct cost of management of COPD ranges from 
61% to 89% of the total cost of health care [3,4]. 
COPD patients typically have several comorbidities, including heart failure, skeletal 
muscle dysfunction, osteoporosis and mental health issues, such as anxiety and depres-
sion [5]. The importance of the psychiatric comorbidity in COPD has recently been 
stressed, and it has been suggested that common mental disorders (CMDs) in COPD pa-
tients are associated with sleep disorders, lacking interests, asthenia, lower levels of self-
efficacy, more frequent exacerbations and more hospital admissions [6,7]. These have a 
serious impact on the patients’ quality of life, coping strategies and adherence to treat-
ment [8,9], contributing to the overall disease burden of COPD [10]. The prevalence of 
depression and anxiety in COPD patients is greater compared to the general population, 
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ranging from 9.8% to 57% in the case of depression [11–14] and from 8.1% to 46% for anx-
iety [11,12,15], although both of these mental disorders are underdiagnosed [16]. Never-
theless, it should be noted that depressive and anxiety symptoms are both correlated to 
pulmonary-specific symptoms among patients with COPD, potentially leading to overes-
timate or misdiagnosis of depression and anxiety, which can be avoided with a robust 
clinical interview [17]. Recent studies have highlighted the influence of age, educational 
status, smoking habits and alcohol consumption on CMDs in COPD sufferers [18,19]. 
However, the role of other characteristics remains controversial. 
COPD significantly affects peoples’ lives, leading to an inability to finish meaningful 
activities [20]. As COPD progresses, individuals experience numerous symptoms, of 
which dyspnea, fatigue and muscle weakness are the most severe [17,21]. This conse-
quently affects their ability to complete both daily life activities, such as dressing, stair 
climbing and household chores, and more complex tasks known as instrumental activities 
of daily living, such as shopping, housework and using public transport and individuals 
suffering from COPD face a difficult process of adaptation to their health condition [22]. 
Even though a number of studies have pointed out that the most widely recognized con-
ditions causing functional limitations among people are rheumatoid arthritis, spine issues 
and cardiovascular disease and that these conditions increase in prevalence as the popu-
lation ages [23,24], Djibo et al. [25] reported that the highest rates of functional limitation 
occur in middle-aged adults (45–64 years old) with COPD, although the reasons for this 
finding are not completely understood. In fact, patterns of functional limitation in activi-
ties of daily living and related determinants, specifically in COPD patients, are currently 
under investigation [26].  
Even though cigarette smoking is one of the most important risk factors for develop-
ment and progression in COPD [27], the symptoms advance even after the patient has quit 
smoking [28]. Hence, there are probably additional modifiable elements which contribute 
to COPD, and these need to be recognized in order to improve patient management. Diet 
is one of the most important lifestyle determinants of health; however, relatively little at-
tention is paid to diet in relation to lung problems and the current dietary guidelines do 
not provide enough information in this regard [29]. Evidence available from previous 
studies suggests that diet is an important contributor to the symptoms, functional limita-
tion and prognosis of COPD [30,31].  
Oxidative stress and associated inflammation are thought to be involved in COPD 
development and progression [32,33]. Diet may contribute to antioxidant/oxidant and in-
flammatory status in COPD. Previous studies have reported the potential beneficial effects 
of foods rich in antioxidants (fruits and vegetables) on the reduction of COPD symptoms 
and incidence [30,34,35]. In addition, a protective effect against development of COPD has 
been suggested for fish consumption. Fish oils are thought to have anti-inflammatory ef-
fects, because of the influence of the n-3 polyunsaturated fatty acids eicosapentaenoic acid 
and docosahexaenoic acid on arachidonic acid metabolism [36]. Moreover, among micro-
nutrients, it has been found a positive association between intake of calcium, phosphorus, 
iron, potassium and selenium and lung function [36]. Other studies support a role for vit-
amin D in preventing and reducing the number of COPD exacerbation [37,38]. Addition-
ally, important diet related factors such as loss of fat free mass [39] and obesity [40] are 
relevant to prognosis, functional limitation and COPD symptoms. Nevertheless, COPD 
patients show an inadequate diet quality, consuming less fruit and vegetables and more 
foods with a lower antioxidant content, compared to a healthy population [34], which is 
considered the major cause of malnutrition in these people. Nowadays, evidence showing 
how sociodemographic and health-related factors contribute to diet quality in this popu-
lation is scarce.  
Previous evidence has showed that COPD is expressed differently in women than in 
men in relation to symptoms, pulmonary function, exacerbations or comorbidities [41] 
and there is therefore a need to clarify the role of gender in this illness, in order to optimize 
the care and attention of these patients.  
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Finally, it should be noted that CMDs can be a cause and a consequence of COPD 
and diet is associated with inflammation, oxidative stress and brain function (which are 
involved in developing CMDs but also may cause impact on COPD disease and progres-
sion). All of these factors are relevant to functional limitation of people. Therefore, the 
sociodemographic and health-related behaviors variation over time can impact on preva-
lence of CMDs, functional limitation and diet quality among individuals with COPD [42]. 
To the best of our knowledge, this study is the first in COPD patients living in Spain to 
measure and analyze the presence of CMDs, functional limitations, diet quality and gen-
der-related factors at the same time. This will provide us with vital data to plan more 
personalized and efficient care programs to deal with COPD. Therefore, the main objec-
tives of the present study were to examine time trends in the prevalence of CMDs, func-
tional limitation and diet quality among male and female COPD patients living in Spain 
from 2006 to 2017, and to identify which characteristics, including sociodemographic, 
health-related variables and the use of clinical preventive care services, were related to 
CMDs, functional limitation and a poor/improvable diet quality among men and women 
suffering from COPD. 
2. Materials and Methods 
2.1. Design, Data Source and Participants 
The data for this nationwide cross-sectional study were obtained from the personal-
ized interviews of the Spanish National Health Survey (SNHS) 2006 [43], the SNHS 2011 
[44] and the SNHS 2017 [45]. The interviews were conducted with community people 
(non-institutionalized) residing in main family dwellings (household) of Spain by the 
Ministry of Health, Consumer Affairs and Social Welfare in partnership with the National 
Institute of Statistics. A three-stage probabilistic design was used, stratifying the data by 
census section, households and persons. The individuals were informed about the survey 
by letter, specifying the reasons for the survey and the voluntary and anonymous nature 
of participation, and about the visit of a suitably approved interviewer.  
All individuals aged ≥40 years old were considered. Those who responded “yes” to 
the query, “Has your doctor told you that you are currently suffering from chronic bron-
chitis, emphysema or COPD?” were identified as suffering from COPD. The sample ini-
tially comprised of 3373 participants (SNSH 2006: n = 1326; SNSH 2011: n = 1002; SNHS 
2017: n = 1045), although 801 (23.8%) subjects were later excluded due to non-response or 
refusal to respond to the questions (SNSH 2006: n = 406; SNSH 2011: n = 212; SNHS 2017: 
n = 183), although their characteristics were similar to the other COPD patients included. 
Finally, the total sample consisted of 2572 subjects: 920 in SNHS 2006; 790 in SNHS 2011; 
and 862 in SNHS 2017. 
2.2. Outcome Measurements 
CMDs. CMDs are defined as minor psychiatric disturbances with a set of non-psy-
chotic depressive, and anxiety symptoms that affect the performance of daily-life activi-
ties. They included symptoms such as fatigue, insomnia, memory lapses, difficulty of con-
centration and irritability [46]. These were identified using the 12-item General Health 
Questionnaire (GHQ-12) [47] in Spain [48,49]. The GHQ-12 detects mainly two types of 
disorders: anxiety and depression. The questionnaire consists of 12 Likert-type items with 
four possible answers from 0 (less than usual) to 3 (much more than usual). It is assigned 
0 points to answers 0 and 1, and 1 point to answers 2 and 3 [50]. The overall score is the 
sum of the points of the 12 items, thus, the total score ranges between 0 and 12 points. A 
cut-off point at ≥3 points was considered, so that the absence of CMDs was determined 
by scores <3 points and their existence denoted by scores ≥3 points, the latter being used 
to indicate the risk of psychological distress [51]. 
Functional limitation. This variable was examined by considering questions focusing 
on different physical tasks in two functional areas [52,53]: (i) basic activities of daily life, 
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which require managing one’s basic physical needs (e.g., personal hygiene, dressing, toi-
leting, transferring or ambulating); (ii) instrumental activities of daily life, which include 
more complex activities related to the ability to live independently in the community (e.g., 
food preparation, managing finances and medications or housekeeping). The level of dif-
ficulty for all items was classified as follows: “I can do it by myself”, “I can do it with 
someone’s help” or “I am unable to do it at all”. We defined the existence of functional 
limitation when subjects answered “I can do it with someone’s help” or “I am unable to 
do it at all” on at least one item for a specific area of functional limitation. 
Diet quality. This was evaluated using the Spanish Health Eating Index (SHEI) [54], 
which is based on the North American Healthy Eating Index [55]. The SHEI includes ten 
food groups (cereals, vegetables, fruit, dairy, meat, legumes, cold meats, sweets, soft 
drinks and dietary variety) divided into five categories (never or hardly ever, < once per 
week, 1–2 times per week, ≥3 times per week, but not daily, and daily), considering the 
Spanish recommendations [56]. The scores referring to each food group ranged from 0 to 
10 points, as shown in Supplementary Table S1. The total score is obtained by adding the 
frequency of consumption of the different food groups. The higher the score, the higher 
the level of agreement with the Spanish recommendations. The overall SHEI score was 
classified taking into account the following cut-offs described previously [55]: >80 points, 
good diet quality; 51–80 points, improvable diet quality; and <51 points, poor diet quality. 
2.3. Sociodemographic Variables, Health-Related Determinants and Clinical Preventive  
Care Services 
The following data were recorded: 
Sociodemographic variables: Year of the surveys (2006, 2011, 2017); gender (women, 
men); age group (40–54 years, 55–69 years, ≥70 years); educational attainment (without 
studies, primary, secondary or professional training, university); town population 
(<10,000 inhabitants, 10,000–100,000 inhabitants, >100,000 inhabitants); living with a part-
ner (yes, no) and occupation (working, non-working). 
Health-related determinants: Body Mass Index (BMI), which was categorized accord-
ing to the cut-offs proposed by the World Health Organization [57] (underweight, normal 
weight, overweight and obese); smoking status (current smokers, ex-smokers or non-
smokers); alcohol intake in the last year (yes, no); leisure-time physical activity (yes, no) 
and number of medical diagnosed of comorbid chronic conditions (myocardial infarction, 
diabetes, chronic heart disease, arthritis, high blood pressure, asthma, cancer and stroke), 
classified as none, one or two and three or more.  
Clinical preventive care services: Blood cholesterol level measurement in the last year 
(yes, no); blood pressure taken by a healthcare professional in the last year (yes, no) and 
influenza vaccination during the last vaccination campaign (yes, no). 
2.4. Procedure and Ethical Considerations 
The anonymized information downloaded is accessible to the general population 
through the National Institute of Statistics and Ministry of Health, Consumer Affairs and 
Social Welfare sites [43–45]. As indicated by Spanish law, Ethics Committee endorsement 
is not required if secondary information is being used. The research data is included in 
the Supplementary File. 
2.5. Statistical Analysis 
Descriptive analysis was carried out using counts, percentages and mean and stand-
ard deviation. Inferential analysis was performed using Chi-square test or Fisher’s exact 
test if the number of expected frequencies was greater than 5. Chi-square trend analysis 
was also performed for the presence of CMDs, physical limitation and poor/improvable 
diet quality taking into account the years of the study. For each dependent variable (CMD, 
functional limitation and diet quality) we fitted multivariate logistic regression models. 
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We included all the variables whose univariate test showed potential association with 
each dependent variable (p ≤ 0.15), and backward selection was used to eliminate non-
significant variables based on the probability of the Wald statistic. Crude and adjusted 
Odds Ratios (OR) were calculated with 95% confidence intervals. The goodness of fit was 
verified with the Hosmer–Lemeshow test. A p-value ≤ 0.05 was considered to be signifi-
cant. All data analyses were performed separately for women and men. The statistical 
analysis was carried out using the IBM SPSS Statistical package version 25 (IBM Corp, 
Armonk, NY, USA), licensed to the University of Cordoba (Spain). 
3. Results 
3.1. Sociodemographic Variables, Health-Related Determinants and Use of Clinical Preventive 
Care Services 
The total sample was made up of 2572 individuals with COPD, including 50.4% (n = 
1295) women and 49.7% (n = 1277) men. The groups did not differ in some variables, in-
cluding level of education, occupation, number of chronic diseases, measurement of blood 
pressure and the amount of total serum cholesterol in the last 12 months and Influenza 
vaccination during the last campaign. In contrast, the men were significantly older (p < 
0.01), were more likely to be classified as overweight (p < 0.01) and reported more fre-
quently doing physical activity during their leisure time (p < 0.01). The women reported 
more frequently living in towns with >100,000 inhabitants (p < 0.01) and not consuming 
tobacco (p < 0.01) or alcohol in the last 12 months (p < 0.01) (Table 1). 
Table 1. Comparison of male and female COPD patients as regards sociodemographic variables, health-related determi-
nants and the use of clinical preventive care services (n = 2572). 
Variables Total n (%) Men n = 1277 (%) Women n = 1295 (%) p-Value 
Educational attainment    
0.05 
Without studies 707 (27.5) 320 (25.0) 387 (29.9) 
Primary 823 (32.0) 423 (33.1) 400 (30.9) 
Secondary or PT 832 (32.3) 422 (33.1) 410 (31.6) 
University 210 (8.2) 112 (8.8) 98 (7.6) 
Town population    
<0.01 
<10,000 inhabitants 687 (26.7) 382 (29.9) 305 (23.5) 
10,000–100,000 inhabitants 850 (33.1) 414 (32.4) 436 (33.7) 
>100,000 inhabitants 1035 (40.2) 481 (37.7) 554 (42.8) 
Living with a partner    
<0.01 Yes 1127 (43.8) 662 (51.8) 465 (35.9) 
No 1445 (56.2) 615 (48.2) 830 (64.1) 
Occupation    
0.67 Working 423 (16.5) 214 (16.8) 209 (16.1) 
Non-working 2149 (83.5) 1063 (83.2) 1086 (83.9) 
Body Mass Index    
<0.01 
Underweight 34 (1.3) 17 (1.3) 17 (1.3) 
Normal weight 720 (28.0) 331 (25.9) 389 (30.0) 
Overweight 1000 (38.9) 565 (44.3) 435 (33.6) 
Obesity 818 (31.8) 364 (28.5) 454 (35.1) 
Smoking status    
<0.01 
Smoker 578 (22.5) 332 (26.0) 246 (19.0) 
Ex-smoker 888 (34.5) 695 (54.4) 193 (14.9) 
Non-smoker 1106 (43.0) 250 (19.6) 856 (66.1) 
Alcohol intake in the last year    
<0.01 
Yes 676 (26.3) 371 (29.1) 305 (23.6) 
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No 1896 (73.7) 906 (70.9) 990 (76.4) 
Leisure-time physical activity    
<0.01 Yes 1364 (53.0) 716 (56.1) 648 (50.0) 
No 1208 (47.00) 561 (43.9) 647 (50.0) 
Number of chronic conditions    
0.17 
0 367 (14.2) 216 (16.9) 151 (11.7) 
1–2 1388 (54.0) 708 (55.5) 680 (52.5) 
≥3 817 (31.8) 353 (27.6) 464 (35.8) 
Measurement of blood pressure in the last 
12 months 
   
0.71 
Yes 227 (8.8) 1167 (91.4) 1178 (91.0) 
No 2345 (91.2) 110 (8.6) 117 (9.0) 
Measurement of the amount of total serum 
cholesterol in the last 12 months 
   
0.94 
Yes 2204 (85.7) 1095 (85.8) 1109 (85.6) 
No 368 (14.3) 182 (14.2) 186 (14.4) 
Influenza vaccination during the last cam-
paign 
   
0.72 
Yes 1481 (57.6) 786 (61.6) 695 (53.7) 
No 1091 (42.4) 491 (38.4) 600 (46.3) 
 Mean (SD) Mean (SD) Mean (SD) p-value 
Age (years old) 67.0 (12.8) 67.8 (12.4) 66.2 (13.1) <0.01 
SD: Standard Deviation; PT: professional training. 
3.2. CMDs, Functional Limitation and Diet Quality 
The women suffered from CMDs more frequently than men (45.5% vs. 30.2%, respec-
tively; p < 0.001). However, the men reported more frequently having poor/improvable 
diet quality than the women (61.3% vs. 53.1%, respectively; p < 0.001). Regarding func-
tional limitation, we found no differences between both groups. Nevertheless, over the 
study years, the prevalence of functional limitation among women with COPD increased 
(p for trend < 0.001) (Figure 1) but not for men (p for trend = 0.32). No significant changes 
were observed in either men or women over the study period in relation to CMDs (men 
in 2006: 31.1%, in 2011: 30.3%, in 2017: 29.2%, p for trend = 0.55; women in 2006: 46.8%, in 
2011: 47.4%, in 2017: 42.4%, p for trend = 0.17) and poor/improvable quality of diet (men 
in 2006: 63.7%, in 2011: 52.2%, in 2017: 67.6%, p for trend = 0.19; women in 2006: 43.8%, in 
2011: 56.8%, in 2017: 41.7%, p for trend = 0.41). 
Table 2 shows the distribution of CMDs, functional limitation and poor/improvable 
diet quality according to the study variables from 2006 to 2017 in men with COPD. We 
observed an increase in the prevalence of CMDs from 2006 to 2017 in workers (2006: 
17.1%, 2011: 23.2%, 2017: 31.9%, p < 0.001). In addition, we found an increase in the prev-
alence of functional limitation in those who had ≥3 chronic conditions (2006: 45.2%, 2011: 
38.5%, 2017: 48.6%, p < 0.001). In relation to poor/improvable diet quality, this variable 
decreased over the study years in individuals who had university studies (2006: 64.9%, 
2011: 44.8%, 2017: 63.0%, p < 0.001). 




Figure 1. Prevalence of functional limitation in COPD patients over time (n = 2572). 
Table 2. Distribution of the CMDs, functional limitation and poor/improvable diet quality according to the study variables 
in men with COPD from 2006 to 2017 (n = 1277). 
 
Common Mental Disorders Functional Limitation Poor/Improvable Diet Quality 
n = 386 n = 344 n = 783 
Variables 
2006 2011 2017 2006 2011 2017 2006 2011 2017 
n = 142 (%) 
n = 123 
(%) 
n = 121 (%) n = 134 (%) n = 101 (%) n = 109 (%) n = 291 (%) n = 272 (%) n = 280 (%) 
Age group          
40–54 15 (25.0) 27 (36.0) 28 (38.4) - - - 48 (80.0) 54 (72.0) 62 (84.9) 
55–69 45 (26.9) 42 (29.0) 37 (25.7) 17 (10.2) 18 (12.4) 13 (9.0) 103 (61.7) 76 (52.4) 97 (67.4) 
≥70 82 (35.7) 54 (29.0) 56 (28.4) 117 (50.9) 83 (44.6) 96 (48.7) 140 (60.9) 82 (44.1) 121 (61.4) 
Educational at-
tainment 
         
Without studies 47 (39.5) 32 (27.1) 32 (38.6) 50 (42.0) 45 (38.1) 39 (47.0) 67 (56.3) 52 (44.1) 56 (67.5) 
Primary 62 (28.7) 28 (32.6) 35 (28.9) 65 (30.1) 18 (20.9) 43 (35.5) 142 (65.7) 40 (46.5) 82 (67.8) 
Secondary or PT 26 (30.6) 60 (34.7) 43 (26.2) 10 (11.8) 32 (18.5) 17 (10.3) 58 (68.2) 107 (61.9) 113 (68.9) 
University 7 (18.9) 3 (10.3) 11 (23.9) 9 (24.3) 6 (20.7) 10 (21.7) 24 (64.9) 1 13 (44.8) 29 (63.0) 
Town popula-
tion 
         
<10,000 inh 43 (28.7) 31 (27.2) 30 (25.4) 44 (29.3) 29 (25.4) 35 (29.7) 100 (66.7) 64 (56.1) 82 (69.5) 
10,000–100,000 
inh 
52 (35.1) 45 (36.9) 50 (34.7) 49 (33.1) 29 (23.8) 44 (30.6) 86 (58.1) 63 (51.6) 95 (66.0) 
>100,000 inh 47 (29.6) 47 (27.7) 41 (27.0) 41 (25.8) 43 (25.3) 30 (19.7) 105 (66.0) 85 (50.0) 103 (67.8) 
Living with a 
partner 
         
Yes 91 (29.9) 39 (22.7) 48 (25.8) 84 (27.6) 48 (27.9) 52 (28.0) 184 (60.5) 86 (50.0) 111 (59.7) 
No 51 (33.3) 84 (35.9) 73 (32.0) 50 (32.7) 53 (22.7) 57 (25.0) 107 (69.9) 126 (53.9) 169 (74.1) 
Occupation          
Working 13 (17.1) 1 16 (23.2) 22 (31.9) - - - 59 (77.6) 45 (65.2) 59 (85.5) 
Non-working 129 (33.9) 107 (31.8) 99 (28.7) 134 (35.2) 101 (30.0) 109 (31.6) 232 (60.9) 167 (49.6) 221 (64.1) 
Body Mass In-
dex 
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Underweight - 2 (33.3) 7 (63.6) - 2 (33.3) 4 (36.4) - 3 (50.0) 5 (45.5) 
Normal weight 49 (35.3) 27 (27.6) 28 (29.8) 38 (27.3) 21 (21.4) 24 (25.5) 93 (66.9) 59 (60.2) 68 (72.3) 
Overweight 54 (28.0) 53 (28.8) 50 (26.6) 66 (34.2) 52 (28.3) 44 (23.4) 118 (61.1) 92 (50.0) 128 (68.1) 
Obesity 39 (31.2) 41 (34.8) 36 (29.8) 30 (24.0) 26 (22.0) 37 (30.6) 80 (64.0) 58 (49.2) 79 (65.3) 
Smoking status          
Smoker 33 (29.7) 42 (35.0) 32 (31.7) 16 (14.4) 13 (10.8) 12 (11.9) 85 (76.6) 87 (72.5) 76 (75.3) 
Ex-smoker 79 (29.9) 56 (28.1) 68 (29.3) 92 (34.9) 62 (31.2) 70 (30.2) 154 (58.3) 85 (42.7) 160 (69.0) 
Non-smoker 30 (36.6) 25 (28.7) 21 (25.9) 26 (31.7) 26 (29.9) 27 (33.3) 52 (63.4) 40 (46.0) 44 (54.3) 
Alcohol intake 
in the last year 
         
Yes 18 (41.9) 12 (30.8) 63 (21.8) 19 (44.2) 4 (10.3) 58 (20.1) 27 (62.8) 14 (35.9) 197 (68.2) 
No 124 (30.0) 111 (30.3) 58 (46.4) 115 (27.8) 97 (26.4) 51 (40.8) 264 (63.8) 198 (54.0) 83 (66.4) 
Leisure-time 
physical activity 
         
Yes 74 (25.7) 41 (21.4) 51 (21.6) 74 (25.7) 27 (14.1) 36 (15.3) 172 (59.7) 87 (45.3) 158 (67.0) 




         
0 21 (26.3) 11 (18.0) 14 (18.7) 12 (15.0) 4 (6.6) 7 (9.3) 60 (75.0) 41 (67.2) 54 (72.0) 
1–2 68 (26.9) 26 (22.8) 21 (20.0) 66 (26.1) 50 (22.4) 50 (21.6) 159 (62.9) 117 (52.5) 158 (68.1) 
≥3 53 (42.7) 26 (23.9) 41 (32.3) 56 (45.2) 1 47 (38.5) 52 (48.6) 72 (58.1) 54 (44.3) 68 (63.6) 
Measurement of 
blood pressure 
in the last 12 
months 
         
Yes 131 (31.3) 112 (30.5) 114 (29.9) 127 (30.3) 95 (25.9) 107 (28.1) 259 (61.8) 188 (51.2) 253 (66.4) 
No 11 (29.0) 11 (28.2) 7 (21.2) 7 (18.4) 6 (15.4) 2 (6.1) 32 (84.2) 24 (61.5) 27 (81.8) 
Measurement of 
the amount of 
total serum cho-
lesterol in the 
last 12 months 
         
Yes 117 (31.5) 102 (28.9) 109 (29.5) 109 (29.3) 93 (26.4) 106 (28.7) 234 (62.9) 179 (50.7) 245 (66.2) 





         
Yes 101 (33.9) 67 (27.7) 66 (26.8) 108 (36.2) 73 (30.2) 77 (31.3) 169 (56.7) 114 (47.1) 150 (61.0) 
No 41 (25.8) 56 (34.2) 55 (32.7) 26 (16.4) 28 (17.1) 32 (19.1) 122 (76.7) 98 (59.8) 130 (77.4) 
PT: professional training; Inh: Inhabitants; 1 p for trend <0.001. 
When comparing the results of the three surveys in women with COPD (Table 3), we 
found an increase in the prevalence of functional limitation over the study years in those 
who were obese (2006: 34.3%, 2011: 36.7%, 2017: 41.0%, p < 0.001) and had ≥3 chronic con-
ditions (2006: 39.3%, 2011: 49.7%, 2017: 57.4%, p < 0.001). Regarding poor/improvable diet 
quality, this variable decreased over the study years in those who had university studies 
(2006: 55.6%, 2011: 44.0%, 2017: 51.4%, p < 0.001). 
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Table 3. Distribution of CMDs, functional limitation and poor/improvable diet quality according to the study variables in 
women with COPD from 2006 to 2017 (N = 1295). 
 
Common Mental Disorders Functional Limitation Poor/Improvable Diet Quality 
n = 589 n = 381 n = 687 
Variables 
2006 2011 2017 2006 2011 2017 2006 2011 2017 
n = 217 (%) n = 182 (%) n = 190 (%) n = 114 (%) n = 108 (%) n = 159 (%) n = 260 (%) n = 166 (%) n = 261 (%) 
Age (years)          
40–54 57 (46.3) 41 (52.6) 37 (51.4) - - - 92 (74.8) 47 (60.2) 54 (75.0) 
55–69 74 (44.3) 72 (48.3) 54 (33.8) 20 (12.0) 16 (10.7) 20 (12.5) 81 (48.5) 60 (40.2) 97 (60.6) 
≥70 86 (49.7) 69 (44.0) 99 (45.8) 94 (54.3) 92 (58.6) 139 (64.4) 87 (50.3) 59 (37.6) 110 (50.9) 
Educational at-
tainment 
         
Without studies 62 (48.4) 67 (52.3) 67 (51.2) 53 (41.4) 60 (46.9) 85 (64.9) 72 (56.3) 59 (46.1) 76 (58.0) 
Primary 105 (48.6) 31 (50.0) 52 (42.6) 48 (22.2) 21 (33.9) 44 (36.1) 117 (54.2) 27 (43.6) 65 (53.3) 
Secondary or PT 37 (44.6) 78 (46.2) 57 (36.1) 9 (10.8) 26 (15.4) 24 (15.2) 51 (61.5) 69 (40.8) 101 (63.9) 
University 13 (36.1) 6 (24.0) 14 (37.8) 4 (11.1) 1 (4.0) 6 (16.2) 20 (55.6) 1 11 (44.0) 19 (51.4) 
Town popula-
tion 
         
<10,000 inh 53 (45.0) 44 (49.9) 35 (36.1) 31 (26.3) 28 (31.1) 39 (40.2) 70 (59.3) 33 (36.7) 57 (58.8) 
10,000–100,000 
inh 
77 (45.0) 63 (53.4) 66 (44.9) 37 (21.6) 33 (28.0) 57 (38.8) 91 (53.2) 64 (54.2) 80 (54.4) 
>100,000 inh 87 (50.0) 75 (42.6) 89 (43.6) 46 (26.4) 47 (26.7) 63 (30.1) 99 (56.9) 69 (39.2) 124 (60.8) 
Living with a 
partner 
         
Yes 112 (45.0) 42 (46.2) 47 (37.6) 41 (16.5) 21 (23.1) 37 (29.6) 138 (55.4) 38 (41.8) 76 (60.8) 
No 105 (49.1) 140 (47.8) 143 (44.2) 73 (34.1) 87 (29.7) 122 (37.8) 122 (57.0) 128 (43.7) 185 (57.3) 
Occupation          
Working 26 (30.6) 19 (30.2) 19 (31.2) 1 (1.2) - 1 (1.6) 54 (63.5) 34 (54.0) 46 (75.4) 
Non-working 191 (50.5) 163 (50.8) 171 (44.2) 113 (29.9) 108 (33.6) 158 (40.8) 206 (54.5) 132 (41.1) 215 (55.6) 
Body Mass In-
dex 
         
Underweight 4 (50.0) 3 (60.0) 3 (75.0) 3 (37.5) - 2 (50.0) 8 (100.0) 3 (60.0) 3 (75.0) 
Normal weight 61 (41.8) 33 (32.7) 61 (43.0) 29 (19.9) 21 (20.8) 48 (33.8) 88 (60.3) 46 (45.5) 81 (57.0) 
Overweight 77 (45.6) 63 (52.5) 59 (40.4) 34 (20.1) 29 (24.2) 45 (30.8) 93 (55.0) 51 (42.5) 84 (57.5) 
Obesity 75 (53.6) 83 (52.5) 67 (43.0) 48 (34.3)1 58 (36.7) 64 (41.0) 71 (50.7) 66 (41.8) 93 (59.6) 
Smoking status          
Smoker 40 (43.0) 46 (59.7) 35 (46.1) 4 (4.3) 3 (3.9) 7 (9.2) 65 (69.9) 54 (70.1) 55 (72.4) 
Ex-smoker 26 (53.1) 18 (32.7) 30 (33.7) 4 (8.2) 7 (12.7) 19 (21.4) 28 (57.1) 17 (100.0) 51 (57.3) 
Non-smoker 151 (47.0) 118 (46.8) 125 (44.2) 106 (33.0) 98 (38.9) 133 (47.0) 167 (52.0) 95 (37.7) 155 (54.8) 
Alcohol intake 
in the last year 
         
Yes 27 (48.2) 20 (41.7) 63 (31.3) 6 (10.7) 6 (12.5) 36 (17.9) 36 (64.3) 25 (52.1) 117 (58.2) 
No 190 (46.7) 162 (48.2) 127 (51.4) 108 (26.5) 102 (30.4) 123 (49.8) 224 (55.0) 141 (42.0) 144 (58.3) 
Leisure-time 
physical activity 
         
Yes 103 (39.9) 65 (36.3) 71 (33.4) 44 (17.1) 22 (12.3) 39 (18.5) 128 (49.6) 71 (39.7) 128 (60.7) 
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0 10 (17.9) 19 (35.9) 14 (33.3) 2 (3.3) 4 (7.6) 5 (11.9) 39 (69.6) 35 (66.0) 31 (73.8) 
1–2 114 (44.4) 69 (37.1) 88 (37.1) 53 (20.6) 32 (17.2) 57 (24.1) 154 (59.9) 75 (40.3) 134 (56.5) 
≥3 93 (62.0) 94 (64.8) 88 (52.1) 59 (39.3)1 72 (49.7) 97 (57.4) 67 (44.7) 56 (38.6) 96 (56.8) 
Measurement of 
blood pressure 
in the last 12 
months 
         
Yes 203 (48.9) 174 (49.3) 177 (43.2) 110 (26.5) 107 (30.3) 156 (38.1) 224 (54.0) 149 (42.2) 238 (58.1) 
No 14 (29.2) 8 (25.8) 13 (34.2) 4 (8.3) 1 (3.2) 3 (7.9) 36 (75.0) 17 (54.8) 23 (60.5) 
Measurement of 
the amount of 
total serum cho-
lesterol in the 
last 12 months 
         
Yes 190 (49.4) 164 (50.3) 171 (43.0) 100 (26.0) 98 (30.1) 154 (38.7) 202 (52.5) 132 (40.5) 223 (56.0) 





         
Yes 118 (45.4) 86 (43.7) 99 (41.6) 90 (34.6) 64 (32.5) 115 (48.3) 143 (55.0) 62 (31.5) 129 (54.2) 
No 99 (48.8) 96 (51.3) 91 (43.3) 24 (11.8) 44 (23.5) 44 (21.0) 117 (57.6) 104 (55.6) 132 (62.9) 
PT: professional training; Inh: Inhabitants; 1 p for trend < 0.001. 
3.3. Association between Sociodemographic Variables, Health-Related Determinants, Use of 
Clinical Preventive Care Services and CMDs, Functional Limitation and Diet Quality 
CMDs, functional limitation and diet quality were distributed differently according 
to the sociodemographic factors, health-related variables and use of clinical preventive 
care services in men with COPD (Table 4). In the adjusted multivariate analysis, the prob-
ability of CMDs was lower among those who were normal weight, had university studies, 
took part in physical activity in their leisure time and who had no or 1–2 chronic condi-
tions, and were higher among those who had consumed alcohol during the last 12 months. 
In addition, having primary, secondary and university studies, participating in physical 
activity during leisure time and having no or 1–2 chronic conditions was associated with 
a lower probability of functional limitation. In relation to diet quality, being between 40–
54 years old and being a smoker were associated with a higher probability of poor/im-
provable diet quality in men with COPD, while taking part in physical activity during 
leisure time decreased that probability.  
Table 4. Association between CMDs, functional limitation and poor/improvable diet quality, and sociodemographic fac-
tors, health-related determinants and use of clinical preventive care services in men with COPD (n = 1277). 
Variables 
Common Mental Disorders Functional Limitation Poor/Improvable Diet Quality 
OR (IC 95%) ORa (IC95%) 
p-
Value 
OR (IC 95%) ORa (IC95%) 
p-
Value 
OR (IC 95%) ORa (IC95%) 
p-
Value 
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1 in the last 12 months; BMI: body mass index; PT: professional training; OR: odds ratio; ORa: odds ratio adjusted for all 
sociodemographic variables, health-related determinants and use of clinical preventive care services; CI 95%: 95% Confi-
dence Interval; Hosmer-Lemeshow test for CMDs χ2 = 4.16, p = 0.84; Nagelkerke’s R2 Square for CMD = 0.11; p-value < 
0.001. Hosmer-Lemeshow test for functional limitation χ2 = 7.32, p = 0.40; Nagelkerke’s R2 Square for functional limitation 
= 0.20; p-value < 0.001. Hosmer-Lemeshow test for poor/improvable diet quality χ2 = 6.48, p = 0.59; Nagelkerke’s R2 Square 
for poor/improvable diet quality = 0.09; p-value < 0.001. 
Table 5 shows the variables associated with the presence of CMDs, functional limita-
tion and poor/improvable diet quality in women with COPD. In the adjusted multivariate 
analysis, the probability of CMDs was higher in those who were smokers and had con-
sumed alcohol in the last year and lower in those who were workers and had no or 1–2 
chronic conditions. Additionally, being between 55–69 years old, having primary, second-
ary or university studies, living with a partner, participating in physical activity during 
leisure time and having no or 1–2 chronic conditions were variables associated with a 
lower probability of functional limitation in women with COPD. Regarding diet quality, 
being between 40–54 years old, being underweight and being a smoker were associated 
with a higher probability of poor/improvable diet quality in women with COPD. 
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Table 5. Association between CMDs, functional limitation and poor/improvable diet quality and sociodemographic fac-
tors, health-related determinants and use of clinical preventive care services in women with COPD (n = 1295). 
Variables 
Common Mental Disorders Functional Limitation Poor/Improvable Diet Quality 
OR (IC 95%) ORa (IC95%) 
p-
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1 in the last 12 months; BMI: body mass index; PT: professional training; OR: odds ratio; ORa: odds ratio adjusted for all 
sociodemographic variables, health-related determinants and use of clinical preventive care services; CI 95%: 95% Confi-
dence Interval; Hosmer-Lemeshow test for CMDs χ2 = 6.51, p = 0.37; Nagelkerke’s R2 Square for CMD = 0.10; p-value < 
0.001. Hosmer-Lemeshow test for functional limitation χ2 = 7.50, p = 0.48; Nagelkerke’s R2 Square for functional limitation 
= 0.54; p-value < 0.001. Hosmer-Lemeshow test for poor/improvable diet quality χ2 = 6.22, p = 0.62; Nagelkerke’s R2 Square 
for poor/improvable diet quality = 0.08; p-value < 0.001. 
4. Discussion 
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4.1. Main Findings Related to Sociodemographic Variables, Health-Related Determinants and 
Use of Clinical Preventive Care Services 
The SNHS has been used previously due to its statistical potential as a representative 
national survey with a substantial sample size. According to previous evidence, the re-
sults of the current study showed that, in comparison to men, women with COPD were 
younger, smoked less, were more frequently obese, lived alone in towns with a greater 
number of inhabitants and took part in less physical activity [58–63]. 
4.2. Main Findings Related to the Presence of a CMD 
In our study, although women suffered from a CMD more frequently than men, 
probably due to their tendency to internalize emotions [13], the prevalence of CMDs in-
creased over time among male workers with COPD. There are complex associations be-
tween COPD, its symptoms, psychological impacts, health-related behaviors and work 
productivity. In that sense, the relationships between anxiety/depression and COPD out-
comes is thought to be cyclical: elevated level of anxiety/depression symptoms may in-
crease negative health-related behaviors, such as smoking, which, in turn, exacerbate 
COPD symptoms being able then further exacerbate anxiety and depression symptoms 
[64] having a direct negative effect on work productivity [65]. On the other hand, alcohol 
consumption was related to a greater likelihood of suffering from CMDs in women and 
men, whereas having none, one or two chronic conditions made it less likely. While sev-
eral studies have found an association between drinking alcohol and COPD and many 
individuals with COPD have been or are heavy drinkers [66,67], there is little research 
into how alcohol use impacts on the mental status of people living with COPD [68]. Con-
sidering the biopsychosocial effects of alcohol use in COPD patients, it therefore seems 
important to design strategies to reduce their alcohol consumption by gender. Especially, 
taking into account that, in the current study, men reported more frequently consuming 
alcohol in the last 12 months compared to women. Moreover, future research should ex-
plore longitudinally whether alcohol consumption is used as a coping strategy with men-
tal disorders, or it is a manifestation of mental distress. Regarding chronic conditions, the 
mechanisms that help to explain the high frequency of major comorbidities in individuals 
with COPD focus on the concept of systemic inflammation in addition to coexisting con-
ditions that one would naturally expect (e.g., due to the patients’ advanced age) and due 
to share risk factors [69]. The link between COPD and mental disorders such as anxiety 
and depression may be systemic inflammation due to spillover [69]. The lower probability 
of CMDs in COPD subjects with no or fewer chronic conditions found in the current study 
could be explained by the fact that these COPD participants are less likely to be function-
ally limited, making them less vulnerable to social isolation, social interaction and de-
pendency on caregivers.  
In addition, in our study, being a worker was associated with a lower probability of 
CMDs in women. In this context, however, the findings from the literature are unclear 
and contradictory. Some authors suggest that employment is beneficial for psychological 
well-being because it temporarily relieves a woman of the stress arising from gender role 
expectations, especially if the woman works full-time and has no children [70]. Our study 
demonstrated that physical activity decreased the probability of suffering from CMDs in 
men with COPD. It has also been reported that men with COPD take part in significantly 
more physical activity than women and that physical activity relieves their symptoms, 
improves their quality of life and decreases the risk of exacerbations [13]. Additionally, in 
the current study, being a smoker was related to an increased likelihood of CMDs in 
women, which supports previous reports [60,71]. Female COPD patients are more likely 
to suffer from depression and anxiety than their male counterparts, with manifestations 
that can be severe [60]. It has been suggested that the relationship between smoking and 
depression/anxiety may be bidirectional, with smoking used to alleviate symptoms and 
these symptoms in turn leading to further smoking [72].  
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In the current study, men with a high educational level had less probability of suffer-
ing from a CMD than men without studies, which is confirmed by international research 
which shows that a greater level of education is related to a better mental health [73]. One 
factor that should be considered is that CMDs are less likely to occur in men than women 
with COPD [15], and men with a high level of education are likely to understand their 
own disease better and implement self-management of COPD, which could contribute to 
better mental health [74]. Few studies have evaluated the relationship between BMI and 
mental problems in individuals with COPD and the findings which do exist are noticeably 
contradictory. While a number of studies noted that a lower BMI is significantly related 
to the development of mental issues in COPD patients [75,76], other authors suggest pos-
itive associations between weight and mental health problems in COPD patients [40]. In 
our study, we found that normal-weight men had less probability of suffering from 
CMDs, which matched results from another study [74]. Therefore, in COPD individuals, 
it has been suggested that BMI levels <21.38 kg/m2 could help to identify COPD individ-
uals with a greater risk of depression [74]. 
4.3. Main Findings Related to Functional Limitation 
The present study reveals that the prevalence of functional limitation increased from 
2006 to 2017 in women with COPD but not in men. Numerous studies have suggested that 
functional limitation seems to decrease [77,78] or increase [79] over time. Previous studies 
have reported some factors that might be responsible for those changes in time in individ-
uals with COPD. Thus, living in a disadvantaged neighborhood is associated with worse 
COPD-related outcomes, including functional limitations [80]. The available evidence has 
also shown that different personalities, resilience or coping styles, as well as paid work 
and a decline in economic conditions could help to explain the variation in the prevalence 
of functional limitation over the years [20,81]. Additionally, it seems that having a pet can 
offer both psychological and physical health benefit decreasing both sedentary lifestyle 
and levels of functional limitation [82]. In women with COPD, one of the reasons behind 
this could be the fact that women’s health is often ignored due to gender disparity; also, 
females with COPD experience a greater risk of exacerbation and more severe symptoms 
than men, producing severe stages of COPD and generating a higher prevalence of func-
tional limitation [25,60]. In the current study, the prevalence of functional limitation in-
creased over time in obese women with COPD. This indicates the relevance of devising 
interventions to reduce functional limitation, including adaptation of the environment 
and studying, at the beginning of the intervention, the activities in which these obese in-
dividuals experience a higher degree of functional limitation. 
Factors associated with a lower probability of suffering from functional limitation in 
both females and males included higher educational attainment, performing physical ac-
tivity during leisure time and having no, one or two chronic diseases. Higher-educated 
individuals may be able to marshal their economic and psychosocial resources to avoid 
functional limitation, premature death and disease, even in circumstances not conducive 
to health [83]. In this regard, Assari et al. [84] observed a protective effect of a higher ed-
ucational level against COPD. As regards performing physical activity during leisure 
time, previous research has indicated that leisure activities are among the first activities 
to be given up among individuals with COPD, as they are not perceived as having as 
much importance as other activities in life [85]. In addition, associations between func-
tional limitation and COPD may be influenced by comorbidities. This result is in line with 
those from previous studies that showed that the number of incident chronic diseases is 
associated with a loss of functional independence [24,86,87]. Our data showed that the 
prevalence of functional limitation increased over time among men and women who suf-
fered from COPD and had ≥3 chronic conditions. As dependence in basic and instrumen-
tal activities of daily life may indicate an early sign of functional decline, intervention 
programs targeting major modifiable comorbidities for COPD might help to reduce the 
risk of functional limitation and its progression in these individuals. 
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Another factor that can influence functional limitation is age. In our study, being be-
tween 55–69 years old decreased the probability of functional limitation in women, but 
not in men. Previous studies show that there is a higher prevalence of arthritis/musculo-
skeletal symptoms in COPD individuals, especially in women [88,89] and that functional 
limitation among those ages is most often attributed to these problems [90]. Despite the 
fact that persons with disabilities generally experience greater barriers in accessing 
healthcare services than the general population [91], women overall have a higher level of 
health-care utilization, make more primary care visits and receive more diagnostic ser-
vices than men [92], which could result in a lower probability of functional limitation in 
women within that age group. 
Our findings showed that 64.09% of women with COPD lived alone. While some 
studies point to a variation from 16.30% [93] to 40% [40], the higher prevalence obtained 
in our study can be due to differences in the aims of the study. Nonetheless, women with 
COPD who lived with a partner were less likely to have functional limitation. Even though 
women are cared for less frequently by their partners [40], the partners of COPD patients 
are an essential factor in helping them to cope with the disease, making them less depend-
ent for daily activities [94]. An early assessment of social status would provide the oppor-
tunity to recognize COPD individuals in greater need of social support and COPD care 
programs given by formal or informal caregivers.  
4.4. Main Findings Related to Diet Quality 
In our analysis, men had a worse diet quality than women. Here, it is crucial to con-
sider the potential gender differences which may influence the different food choices [95]. 
Moreover, our results showed that the prevalence of poor/improvable diet quality de-
creased from 2006 to 2017 among men and women with higher levels of education, prob-
ably due to the fact that better-educated individuals generally have a greater ability to 
cook and comprehend dietary guidelines, as well as a higher capacity to understand nu-
tritional interventions [36]. Additionally, the findings of the current study showed that 
the likelihood of poor/improvable diet quality was greater in individuals who were be-
tween 40–54 years old and were smokers in both genders. In relation to age, these findings 
could be explained by people’s tendency to improve their diet as they get older, as they 
look after themselves more, which reduces the impact exerted by early-life and cumula-
tive dietary choices on later-life COPD development and progression [36]. On the other 
hand, in the general population, smokers have significantly lower diet quality scores in 
relation to non-smokers [96], which was consistent with our results. In this context, it has 
been reported that tobacco smoke may lead to the dysregulation of appetite and changes 
in the sense of taste, which may lead smokers to choose certain foods over others [97]. 
Generally, the dietary habits of smokers are defined by higher intakes of energy, saturated 
fat, cholesterol and alcohol and by lower intakes of antioxidant vitamins and fiber [98]. 
This suggests that some of these differences may aggravate the harmful effects of the com-
ponents in tobacco smoke on COPD [99].  
For underweight women with COPD, the likelihood of poor/improvable diet quality 
was greater. Women with COPD have a higher prevalence of low BMI than their male 
counterparts [59]. Indeed, previous studies have shown that COPD subjects with low BMI 
have a shorter period of survival [99] and a greater risk of acute exacerbations with worse 
airflow limitation, higher level of inflammation biomarkers and poorer health status [100].  
In the current study, male COPD patients who took part in physical activity had a 
lower likelihood of poor/improvable diet quality. A recent study carried out in Spanish 
individuals with COPD reported that males are more likely to be involved in physical 
activity [101]. Being physically active reduces the risk of hospitalization and daily symp-
toms of dyspnea and fatigue, improves quality of life and predicts an increase in healthy 
dietary patterns [102–104]. 
4.5. Strengths and Limitations 
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The present study has certain limitations. First, since it was a cross-sectional study, 
the causality cannot be demonstrated. Second, the definition of COPD used was based on 
self-reported physician-diagnosis, although it must be mentioned that this definition has 
been commonly used in large national and international surveys [13,84,105]. Third, dis-
ease severity, such as lung function or exacerbations, was not measured and psychological 
symptoms and limitations are both related to disease severity so that the interpretation of 
the data should be done with caution. Fourth, the use of the SHEI to assess the diet quality 
did not show the frequency of consumption by quantities of food or energy; however, the 
validity of the Health Eating Index (HEI) has been demonstrated in studies with plasma 
biomarkers [106,107]. Fifth, the use of yes/no responses on alcohol intake and leisure ac-
tivity can result in loss of granularity due to does not allows understanding of the harm 
from hazardous alcohol consumption or discriminate in terms of healthy behaviors. Sixth, 
BMI was calculated from the heights and weights reported by the subjects, which may not 
be accurate. Finally, due to the fact that data from SNHS is stored anonymously, it is im-
possible to know if a participant has taken part in more than one survey. On the other 
hand, the strength of the current study includes the use of national standardized repre-
sentative surveys with a large sample size. 
4.6. Implications for Research and Practice 
The findings of the current study have a number of potential implications for re-
search and clinical practice. Firstly, as regards diet quality, our findings require confirma-
tion in prospective cohorts, but suggest the need to consider gender differences in the 
selected sociodemographic characteristics and lifestyle factors in order to optimize the 
management of COPD patients by designing suitable dietary guidelines for a diet which 
is beneficial for lung health. Secondly, CMDs should be assessed in routine care and af-
fective factors should be properly monitored in COPD patients. Additionally, further in-
terventions based on cognitive behavioral therapy are needed, as they appear to be effec-
tive in improving CMDs in COPD sufferers [108]. This could be accomplished by using 
self-report measures as part of the regular screening in both primary care and pulmonary 
clinics. Finally, measuring functional limitation in people with COPD in addition to their 
sociodemographic and lifestyle characteristics may reveal how functional limitations af-
fect an individual’s independence and generate information to help us design more per-
sonalized and efficient care programs. Given the diverse membership of the health care 
teams involved in the care of individuals living with COPD, there is a need for collabora-
tive interdisciplinary work to engage the care workers as active participants in their care 
and in the decision-making processes related to their health. 
5. Conclusions 
This study shows an increased prevalence of functional limitation among women 
with COPD over time. Moreover, we observed that the number of men with COPD who 
suffered from CMDs increased from 2006 to 2017. In the same way, the prevalence of func-
tional limitation increased among male and female COPD patients who had ≥3 chronic 
conditions and in female COPD patients who were obese. Conversely, the prevalence of 
poor/improvable diet quality decreased over time in men and women with COPD who 
had university studies. In men, CMDs were associated with BMI, educational level, phys-
ical activity, chronic conditions and alcohol consumption and the presence of functional 
limitation was related to educational level, physical activity and chronic conditions. In 
addition, poor/improvable diet quality was associated to age, smoking status and physical 
activity. In women, CMDs were linked with BMI, educational level, smoking status, oc-
cupation, alcohol consumption and chronic disease, and the presence of functional limi-
tation was associated with age, educational level, living with a partner, physical activity 
and chronic conditions. Finally, poor/improvable diet quality was associated with age, 
BMI and smoking status. 
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